Jim Simons
AGIO icon

Jim Simons’s Agios Pharmaceuticals AGIO Stock Holding History

Jim Simons’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,714
Closed -$430K – 3453
2024
Q1 		$430K Sell
14,714
-28,000
-66% -$750K ﹤0.01% 2920
2023
Q4 		$951K Buy
+42,714
New +$957K ﹤0.01% 2440
2022
Q4 		– Sell
-31,000
Closed -$877K – 4085
2022
Q3 		$877K Sell
31,000
-31,000
-50% -$832K ﹤0.01% 2574
2022
Q2 		$1.38M Buy
+62,000
New +$1.4M ﹤0.01% 2484
2020
Q4 		– Sell
-74,800
Closed -$2.62M – 3350
2020
Q3 		$2.62M Buy
+74,800
New +$3.28M ﹤0.01% 1972
2019
Q4 		– Sell
-121,000
Closed -$3.92M – 3478
2019
Q3 		$3.92M Buy
121,000
+70,700
+141% +$2.93M ﹤0.01% 1934
2019
Q2 		$2.51M Buy
+50,300
New +$2.69M ﹤0.01% 2219
2018
Q2 		– Sell
-69,100
Closed -$5.65M – 3232
2018
Q1 		$5.65M Buy
+69,100
New +$5.34M 0.01% 1735
2014
Q4 		– Sell
-15,900
Closed -$975K – 2943
2014
Q3 		$975K Buy
+15,900
New +$685K ﹤0.01% 2039

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jim Simons's AGIO Position: Q2 2024 in Review

Jim Simons sold out of Agios Pharmaceuticals (AGIO) in Q2 2024, closing a stake of 14,714 shares — an estimated $430K sold.

Jim Simons first reported a position in AGIO in Q3 2014 and held it in 9 quarters. The position peaked at $5.65M in Q1 2018. 206 funds tracked by Wall St. Rank hold AGIO as of Q2 2024.

  • Jim Simons reported no remaining Agios Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Jim Simons sold 14,714 Agios Pharmaceuticals shares in Q2 2024, an estimated $430K.
  • Jim Simons first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 9 quarters.
  • Jim Simons's Agios Pharmaceuticals position peaked at $5.65M in Q1 2018.
  • 206 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.